Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets Recall
Issued December 23, 2020 · GSK Consumer Healthcare · 433,600 units affected
In December 2020, GSK Consumer Healthcare recalled the Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets, a low-risk other recall reported by the CPSC.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, children could access and swallow the contents, posing a risk of poisoning. These products contain the substances aspirin and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA).
What you should do
- 1 Stop using Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact GSK Consumer Healthcare to arrange your refund. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Recall details
- Brand
- GSK Consumer Healthcare
- Category
- Other
- Recall date
- December 23, 2020
- Units affected
- 433,600
- Sold at
- Pharmacies, department stores, grocery stores, and hypermarkets nationwide and online from March 2018 through September 2020 for between $7 and $18.
- Recall number
- CPSC-21057
- Made in
- United States
- Issuing agency
- CPSC
In context
- GSK Consumer Healthcare has 1 recall in our database.
- We're tracking 315 Other recalls in our database.
- 433,600 units is enough to reach roughly 1 in every 302 US households.
- This is the 63rd Other recall we've logged in 2020.